Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 17, 2018
Patent Application Number
15712366
Date Filed
September 22, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of disease or conditions in which HNE is implicated.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
